0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Equine Pharmaceuticals and Supplements Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-79
Home | Market Reports | Pets & Animals | Animal Products & Services | Pet Food & Supplies
Global Equine Pharmaceuticals and Supplements Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Equine Pharmaceuticals and Supplements Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Auto-79
Report
July 2021
122 Pages
QYResearch
Region: Global, Europe, North America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
Market Analysis and Insights: Global Equine Pharmaceuticals and Supplements Market

In 2020, the global Equine Pharmaceuticals and Supplements market size was US$ 1104 million and it is expected to reach US$ 1495 million by the end of 2027, with a CAGR of 4.5% during 2021-2027.

Global Equine Pharmaceuticals and Supplements Scope and Market Size
Equine Pharmaceuticals and Supplements market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Equine Pharmaceuticals and Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Equine Pharmaceuticals and Supplements market is segmented into

Pharmaceuticals
Supplements

Segment by Application, the Equine Pharmaceuticals and Supplements market is segmented into

Thoroughbred Horse
Other Types of Horses
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Equine Pharmaceuticals and Supplements Market Share Analysis
Equine Pharmaceuticals and Supplements market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Equine Pharmaceuticals and Supplements product introduction, recent developments, Equine Pharmaceuticals and Supplements sales by region, type, application and by sales channel.
The major companies include:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
1 Study Coverage
1.1 Equine Pharmaceuticals and Supplements Product Introduction
1.2 Market by Type
1.2.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Market by Application
1.3.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application
1.3.2 Thoroughbred Horse
1.3.3 Other Types of Horses
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Equine Pharmaceuticals and Supplements Market Size Estimates and Forecasts
2.1.1 Global Equine Pharmaceuticals and Supplements Revenue 2016-2027
2.1.2 Global Equine Pharmaceuticals and Supplements Sales 2016-2027
2.2 Equine Pharmaceuticals and Supplements Market Size by Region: 2021 Versus 2027
2.3 Equine Pharmaceuticals and Supplements Sales by Region (2016-2027)
2.3.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2016-2021
2.3.2 Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2022-2027)
2.3.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2027)
2.4 Equine Pharmaceuticals and Supplements Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2016-2021
2.4.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2022-2027)
2.4.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2027)
3 Global Equine Pharmaceuticals and Supplements by Manufacturers
3.1 Global Top Equine Pharmaceuticals and Supplements Manufacturers by Sales
3.1.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2016-2021)
3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Equine Pharmaceuticals and Supplements Manufacturers by Revenue
3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2016-2021)
3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturer (2016-2021)
3.3 Global Equine Pharmaceuticals and Supplements Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Equine Pharmaceuticals and Supplements Manufacturers Covered: Ranking by Revenue
3.4.2 Global Equine Pharmaceuticals and Supplements Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution, Product Type
3.5.1 Equine Pharmaceuticals and Supplements Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Equine Pharmaceuticals and Supplements Product Type
3.5.3 Date of International Manufacturers Enter into Equine Pharmaceuticals and Supplements Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Boehringer Ingelheim
4.1.1 Boehringer Ingelheim Corporation Information
4.1.2 Boehringer Ingelheim Description, Business Overview
4.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Products Offered
4.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Product
4.1.6 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Application
4.1.7 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.1.8 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.1.9 Boehringer Ingelheim Recent Development
4.2 Merck Animal Health
4.2.1 Merck Animal Health Corporation Information
4.2.2 Merck Animal Health Description, Business Overview
4.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Products Offered
4.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Product
4.2.6 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Application
4.2.7 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.2.8 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.2.9 Merck Animal Health Recent Development
4.3 Zoetis
4.3.1 Zoetis Corporation Information
4.3.2 Zoetis Description, Business Overview
4.3.3 Zoetis Equine Pharmaceuticals and Supplements Products Offered
4.3.4 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Zoetis Equine Pharmaceuticals and Supplements Revenue by Product
4.3.6 Zoetis Equine Pharmaceuticals and Supplements Revenue by Application
4.3.7 Zoetis Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.3.8 Zoetis Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.3.9 Zoetis Recent Development
4.4 Bayer Animal Health
4.4.1 Bayer Animal Health Corporation Information
4.4.2 Bayer Animal Health Description, Business Overview
4.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Products Offered
4.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Product
4.4.6 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Application
4.4.7 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.4.8 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.4.9 Bayer Animal Health Recent Development
4.5 Elanco Animal Health
4.5.1 Elanco Animal Health Corporation Information
4.5.2 Elanco Animal Health Description, Business Overview
4.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Products Offered
4.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Product
4.5.6 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Application
4.5.7 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.5.8 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.5.9 Elanco Animal Health Recent Development
4.6 Dechra Veterinary Products
4.6.1 Dechra Veterinary Products Corporation Information
4.6.2 Dechra Veterinary Products Description, Business Overview
4.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Products Offered
4.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Product
4.6.6 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Application
4.6.7 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.6.8 Dechra Veterinary Products Recent Development
4.7 CEVA
4.7.1 CEVA Corporation Information
4.7.2 CEVA Description, Business Overview
4.7.3 CEVA Equine Pharmaceuticals and Supplements Products Offered
4.7.4 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.7.5 CEVA Equine Pharmaceuticals and Supplements Revenue by Product
4.7.6 CEVA Equine Pharmaceuticals and Supplements Revenue by Application
4.7.7 CEVA Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.7.8 CEVA Recent Development
4.8 Virbac
4.8.1 Virbac Corporation Information
4.8.2 Virbac Description, Business Overview
4.8.3 Virbac Equine Pharmaceuticals and Supplements Products Offered
4.8.4 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Virbac Equine Pharmaceuticals and Supplements Revenue by Product
4.8.6 Virbac Equine Pharmaceuticals and Supplements Revenue by Application
4.8.7 Virbac Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.8.8 Virbac Recent Development
4.9 Norbrook Equine
4.9.1 Norbrook Equine Corporation Information
4.9.2 Norbrook Equine Description, Business Overview
4.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Products Offered
4.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Product
4.9.6 Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Application
4.9.7 Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.9.8 Norbrook Equine Recent Development
4.10 Kyoritsu Seiyaku
4.10.1 Kyoritsu Seiyaku Corporation Information
4.10.2 Kyoritsu Seiyaku Description, Business Overview
4.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Products Offered
4.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Product
4.10.6 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Application
4.10.7 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.10.8 Kyoritsu Seiyaku Recent Development
4.11 Vetoquinol
4.11.1 Vetoquinol Corporation Information
4.11.2 Vetoquinol Description, Business Overview
4.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Products Offered
4.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Product
4.11.6 Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Application
4.11.7 Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.11.8 Vetoquinol Recent Development
4.12 Protexin Healthcare
4.12.1 Protexin Healthcare Corporation Information
4.12.2 Protexin Healthcare Description, Business Overview
4.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Products Offered
4.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Product
4.12.6 Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Application
4.12.7 Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.12.8 Protexin Healthcare Recent Development
4.13 Audevard
4.13.1 Audevard Corporation Information
4.13.2 Audevard Description, Business Overview
4.13.3 Audevard Equine Pharmaceuticals and Supplements Products Offered
4.13.4 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Audevard Equine Pharmaceuticals and Supplements Revenue by Product
4.13.6 Audevard Equine Pharmaceuticals and Supplements Revenue by Application
4.13.7 Audevard Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.13.8 Audevard Recent Development
4.14 Ouro Fino Saude
4.14.1 Ouro Fino Saude Corporation Information
4.14.2 Ouro Fino Saude Description, Business Overview
4.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Products Offered
4.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Product
4.14.6 Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Application
4.14.7 Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.14.8 Ouro Fino Saude Recent Development
5 Breakdown Data by Type
5.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2016-2027)
5.1.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2016-2021)
5.1.2 Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2022-2027)
5.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
5.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2016-2027)
5.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021)
5.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2022-2027)
5.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
5.3 Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2016-2027)
6.1.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2016-2021)
6.1.2 Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2022-2027)
6.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
6.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2016-2027)
6.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021)
6.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2022-2027)
6.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
6.3 Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Equine Pharmaceuticals and Supplements Market Size YoY Growth 2016-2027
7.2 North America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
7.2.1 North America Equine Pharmaceuticals and Supplements Sales by Country (2016-2027)
7.2.2 North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2027)
7.3 North America Equine Pharmaceuticals and Supplements Sales by Type
7.4 North America Equine Pharmaceuticals and Supplements Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Equine Pharmaceuticals and Supplements Market Facts & Figures by Region
8.2.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2016-2027)
8.2.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2016-2027)
8.3 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type
8.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application
9 Europe
9.1 Europe Equine Pharmaceuticals and Supplements Market Size YoY Growth 2016-2027
9.2 Europe Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
9.2.1 Europe Equine Pharmaceuticals and Supplements Sales by Country (2016-2027)
9.2.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2027)
9.3 Europe Equine Pharmaceuticals and Supplements Sales by Type
9.4 Europe Equine Pharmaceuticals and Supplements Sales by Application
10 Latin America
10.1 Latin America Equine Pharmaceuticals and Supplements Market Size YoY Growth 2016-2027
10.2 Latin America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
10.2.1 Latin America Equine Pharmaceuticals and Supplements Sales by Country (2016-2027)
10.2.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2027)
10.3 Latin America Equine Pharmaceuticals and Supplements Sales by Type
10.4 Latin America Equine Pharmaceuticals and Supplements Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
11.2.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2027)
11.2.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2027)
11.3 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type
11.4 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Equine Pharmaceuticals and Supplements Supply Chain Analysis
12.2 Equine Pharmaceuticals and Supplements Key Raw Materials and Upstream Suppliers
12.3 Equine Pharmaceuticals and Supplements Clients Analysis
12.4 Equine Pharmaceuticals and Supplements Sales Channel and Sales Model Analysis
12.4.1 Equine Pharmaceuticals and Supplements Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Equine Pharmaceuticals and Supplements Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Equine Pharmaceuticals and Supplements Distributors
13 Market Dynamics
13.1 Equine Pharmaceuticals and Supplements Market Drivers
13.2 Equine Pharmaceuticals and Supplements Market Opportunities
13.3 Equine Pharmaceuticals and Supplements Market Challenges
13.4 Equine Pharmaceuticals and Supplements Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Pharmaceuticals
    Table 3. Major Manufacturers of Supplements
    Table 4. Global Equine Pharmaceuticals and Supplements Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 5. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2021 VS 2027
    Table 6. Global Equine Pharmaceuticals and Supplements Sales by Region (2016-2021) & (K Units)
    Table 7. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2022-2027) & (K Units)
    Table 8. Global Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021) & (US$ Million)
    Table 9. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 10. Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2016-2021) & (K Units)
    Table 11. Global Equine Pharmaceuticals and Supplements Sales Share by Manufacturer (2016-2021)
    Table 12. Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 13. Equine Pharmaceuticals and Supplements Revenue Share by Manufacturer (2016-2021)
    Table 14. Key Manufacturers Equine Pharmaceuticals and Supplements Price (2016-2021) & (USD/Unit)
    Table 15. Ranking of Global Top Equine Pharmaceuticals and Supplements Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 17. Global Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2020)
    Table 18. Equine Pharmaceuticals and Supplements Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Equine Pharmaceuticals and Supplements Product Type
    Table 20. Date of International Manufacturers Enter into Equine Pharmaceuticals and Supplements Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Boehringer Ingelheim Corporation Information
    Table 23. Boehringer Ingelheim Description and Business Overview
    Table 24. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 25. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product
    Table 26. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 27. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 28. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 29. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel
    Table 30. Boehringer Ingelheim Recent Development
    Table 31. Merck Animal Health Corporation Information
    Table 32. Merck Animal Health Description and Business Overview
    Table 33. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 34. Merck Animal Health Equine Pharmaceuticals and Supplements Product
    Table 35. Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 36. Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 37. Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 38. Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel
    Table 39. Merck Animal Health Recent Development
    Table 40. Zoetis Corporation Information
    Table 41. Zoetis Description and Business Overview
    Table 42. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 43. Zoetis Equine Pharmaceuticals and Supplements Product
    Table 44. Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 45. Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 46. Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 47. Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel
    Table 48. Zoetis Recent Development
    Table 49. Bayer Animal Health Corporation Information
    Table 50. Bayer Animal Health Description and Business Overview
    Table 51. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 52. Bayer Animal Health Equine Pharmaceuticals and Supplements Product
    Table 53. Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 54. Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 55. Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 56. Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel
    Table 57. Bayer Animal Health Recent Development
    Table 58. Elanco Animal Health Corporation Information
    Table 59. Elanco Animal Health Description and Business Overview
    Table 60. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 61. Elanco Animal Health Equine Pharmaceuticals and Supplements Product
    Table 62. Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 63. Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 64. Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 65. Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel
    Table 66. Elanco Animal Health Recent Development
    Table 67. Dechra Veterinary Products Corporation Information
    Table 68. Dechra Veterinary Products Description and Business Overview
    Table 69. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 70. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product
    Table 71. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 72. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 73. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 74. Dechra Veterinary Products Recent Development
    Table 75. CEVA Corporation Information
    Table 76. CEVA Description and Business Overview
    Table 77. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 78. CEVA Equine Pharmaceuticals and Supplements Product
    Table 79. CEVA Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 80. CEVA Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 81. CEVA Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 82. CEVA Recent Development
    Table 83. Virbac Corporation Information
    Table 84. Virbac Description and Business Overview
    Table 85. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 86. Virbac Equine Pharmaceuticals and Supplements Product
    Table 87. Virbac Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 88. Virbac Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 89. Virbac Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 90. Virbac Recent Development
    Table 91. Norbrook Equine Corporation Information
    Table 92. Norbrook Equine Description and Business Overview
    Table 93. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 94. Norbrook Equine Equine Pharmaceuticals and Supplements Product
    Table 95. Norbrook Equine Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 96. Norbrook Equine Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 97. Norbrook Equine Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 98. Norbrook Equine Recent Development
    Table 99. Kyoritsu Seiyaku Corporation Information
    Table 100. Kyoritsu Seiyaku Description and Business Overview
    Table 101. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 102. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product
    Table 103. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 104. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 105. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 106. Kyoritsu Seiyaku Recent Development
    Table 107. Vetoquinol Corporation Information
    Table 108. Vetoquinol Description and Business Overview
    Table 109. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 110. Vetoquinol Equine Pharmaceuticals and Supplements Product
    Table 111. Vetoquinol Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 112. Vetoquinol Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 113. Vetoquinol Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 114. Vetoquinol Recent Development
    Table 115. Protexin Healthcare Corporation Information
    Table 116. Protexin Healthcare Description and Business Overview
    Table 117. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 118. Protexin Healthcare Equine Pharmaceuticals and Supplements Product
    Table 119. Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 120. Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 121. Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 122. Protexin Healthcare Recent Development
    Table 123. Audevard Corporation Information
    Table 124. Audevard Description and Business Overview
    Table 125. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 126. Audevard Equine Pharmaceuticals and Supplements Product
    Table 127. Audevard Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 128. Audevard Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 129. Audevard Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 130. Audevard Recent Development
    Table 131. Ouro Fino Saude Corporation Information
    Table 132. Ouro Fino Saude Description and Business Overview
    Table 133. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 134. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product
    Table 135. Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product
    Table 136. Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application
    Table 137. Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area
    Table 138. Ouro Fino Saude Recent Development
    Table 139. Global Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 140. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2022-2027) & (K Units)
    Table 141. Global Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021) & (US$ Million)
    Table 142. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 143. Global Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 144. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2022-2027) & (K Units)
    Table 145. Global Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021) & (US$ Million)
    Table 146. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 147. North America Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
    Table 148. North America Equine Pharmaceuticals and Supplements Sales by Country (2022-2027) & (K Units)
    Table 149. North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & (US$ Million)
    Table 150. North America Equine Pharmaceuticals and Supplements Revenue by Country (2022-2027) & (US$ Million)
    Table 151. North America Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 152. North America Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 153. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2016-2021) & (K Units)
    Table 154. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2022-2027) & (K Units)
    Table 155. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2016-2027) & (US$ Million)
    Table 156. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2022-2027) & (US$ Million)
    Table 157. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 158. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 159. Europe Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
    Table 160. Europe Equine Pharmaceuticals and Supplements Sales by Country (2022-2027) & (K Units)
    Table 161. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & (US$ Million)
    Table 162. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2022-2027) & (US$ Million)
    Table 163. Europe Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 164. Europe Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 165. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
    Table 166. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2022-2027) & (K Units)
    Table 167. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & (US$ Million)
    Table 168. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2022-2027) & (US$ Million)
    Table 169. Latin America Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 170. Latin America Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 171. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
    Table 172. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2022-2027) & (K Units)
    Table 173. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & (US$ Million)
    Table 174. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2022-2027) & (US$ Million)
    Table 175. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
    Table 176. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
    Table 177. Equine Pharmaceuticals and Supplements Key Raw Materials, Industry Status and Trend
    Table 178. Equine Pharmaceuticals and Supplements Key Raw Materials and Upstream Suppliers
    Table 179. Equine Pharmaceuticals and Supplements Clients Status and Trend
    Table 180. Equine Pharmaceuticals and Supplements Typical Clients
    Table 181. Equine Pharmaceuticals and Supplements Distributors
    Table 182. Key Drivers: Impact Analysis (2022-2027)
    Table 183. Equine Pharmaceuticals and Supplements Market Drivers
    Table 184. Equine Pharmaceuticals and Supplements Market Opportunities
    Table 185. Equine Pharmaceuticals and Supplements Market Challenges
    Table 186. Equine Pharmaceuticals and Supplements Market Restraints
    Table 187. Equine Pharmaceuticals and Supplements Porter’s Five Forces Analysis
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Equine Pharmaceuticals and Supplements Product Picture
    Figure 2. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2021 & 2027
    Figure 3. Pharmaceuticals Product Picture
    Figure 4. Supplements Product Picture
    Figure 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2021 & 2027
    Figure 6. Thoroughbred Horse Examples
    Figure 7. Other Types of Horses Examples
    Figure 8. Equine Pharmaceuticals and Supplements Report Years Considered
    Figure 9. Global Equine Pharmaceuticals and Supplements Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Equine Pharmaceuticals and Supplements Market Size 2016-2027 (US$ Million)
    Figure 11. Global Equine Pharmaceuticals and Supplements Sales 2016-2027 (K Units)
    Figure 12. Global Equine Pharmaceuticals and Supplements Market Size Market Share by Region: 2021 Versus 2027
    Figure 13. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Region (2016-2027)
    Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2027)
    Figure 15. Global Equine Pharmaceuticals and Supplements Sales Share by Manufacturer in 2020
    Figure 16. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 17. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2016-2027)
    Figure 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Type (2016-2027)
    Figure 19. Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 20. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Application (2016-2027)
    Figure 21. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Application (2016-2027)
    Figure 22. Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 23. North America Equine Pharmaceuticals and Supplements Revenue 2016-2027 (US$ Million)
    Figure 24. North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
    Figure 25. North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
    Figure 26. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue 2016-2027 (US$ Million)
    Figure 27. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2027)
    Figure 28. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2027)
    Figure 29. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
    Figure 30. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
    Figure 31. Europe Equine Pharmaceuticals and Supplements Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2027)
    Figure 33. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2027)
    Figure 34. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
    Figure 35. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
    Figure 36. Latin America Equine Pharmaceuticals and Supplements Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 37. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2027)
    Figure 38. Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2021)
    Figure 39. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
    Figure 40. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
    Figure 41. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 42. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2027)
    Figure 43. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2027)
    Figure 44. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
    Figure 45. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
    Figure 46. Equine Pharmaceuticals and Supplements Supply Chain (Upstream and Downstream Market)
    Figure 47. Global Production Market Share of Equine Pharmaceuticals and Supplements Raw Materials by Region in 2020
    Figure 48. Equine Pharmaceuticals and Supplements Distribution Channels
    Figure 49. Global Equine Pharmaceuticals and Supplements Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 50. Global Equine Pharmaceuticals and Supplements Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 51. Porter's Five Forces Analysis
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global and United States Cat Litter Products Market Insights Forecast to 2027
Global and United States Cat Litter Products Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-3N7586
Sat Nov 20 00:00:00 UTC 2021

Add to Cart

Global and United States Small Mammal and Reptile Food Market Insights Forecast to 2027
Global and United States Small Mammal and Reptile Food Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-8P7319
Tue Nov 02 00:00:00 UTC 2021

Add to Cart

China Equine Pharmaceuticals and Supplements Market Report Forecast 2021 2027
China Equine Pharmaceuticals and Supplements Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34V6752
Tue Oct 26 00:00:00 UTC 2021

Add to Cart

China Aquarium Lighting Equipment Market Report Forecast 2021 2027
China Aquarium Lighting Equipment Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-9137
Sat Oct 02 00:00:00 UTC 2021

Add to Cart